111 related articles for article (PubMed ID: 29741901)
1. Stereoselective Metabolism of Omeprazole by Cytochrome P450 2C19 and 3A4: Mechanistic Insights from DFT Study.
Jana K; Bandyopadhyay T; Ganguly B
J Phys Chem B; 2018 Jun; 122(22):5765-5775. PubMed ID: 29741901
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes.
Abelö A; Andersson TB; Antonsson M; Naudot AK; Skånberg I; Weidolf L
Drug Metab Dispos; 2000 Aug; 28(8):966-72. PubMed ID: 10901708
[TBL] [Abstract][Full Text] [Related]
4. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
5. Enantiomer/enantiomer interactions between the S- and R- isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4.
Li XQ; Weidolf L; Simonsson R; Andersson TB
J Pharmacol Exp Ther; 2005 Nov; 315(2):777-87. PubMed ID: 16093273
[TBL] [Abstract][Full Text] [Related]
6. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
Jana K; Bandyopadhyay T; Ganguly B
J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
[TBL] [Abstract][Full Text] [Related]
7. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.
Kim KA; Kim MJ; Park JY; Shon JH; Yoon YR; Lee SS; Liu KH; Chun JH; Hyun MH; Shin JG
Drug Metab Dispos; 2003 Oct; 31(10):1227-34. PubMed ID: 12975331
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylation of R(+)- and S(-)-omeprazole after racemic dosing are different among the CYP2C19 genotypes.
Shiohira H; Yasui-Furukori N; Yamada S; Tateishi T; Akamine Y; Uno T
Pharm Res; 2012 Aug; 29(8):2310-6. PubMed ID: 22549736
[TBL] [Abstract][Full Text] [Related]
10. Computational evidence for α-nitrosamino radical as initial metabolite for both the P450 dealkylation and denitrosation of carcinogenic nitrosamines.
Ji L; Schüürmann G
J Phys Chem B; 2012 Jan; 116(2):903-12. PubMed ID: 22136655
[TBL] [Abstract][Full Text] [Related]
11. Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole.
Fan L; Wang G; Wang LS; Chen Y; Zhang W; Huang YF; Huang RX; Hu DL; Wang D; Zhou HH
Acta Pharmacol Sin; 2007 Oct; 28(10):1685-92. PubMed ID: 17883958
[TBL] [Abstract][Full Text] [Related]
12. Theoretical Insights into Imidazolidine Oxidation of Imidacloprid by Cytochrome P450 3A4.
Zheng ML; Li CR; Bai QH; Xiao H; Hu W; Xue Y; Gao JY
J Mol Graph Model; 2018 Mar; 80():173-181. PubMed ID: 29414036
[TBL] [Abstract][Full Text] [Related]
13. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
[TBL] [Abstract][Full Text] [Related]
14. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
Chiba K; Kobayashi K; Manabe K; Tani M; Kamataki T; Ishizaki T
J Pharmacol Exp Ther; 1993 Jul; 266(1):52-9. PubMed ID: 8331574
[TBL] [Abstract][Full Text] [Related]
15. 5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.
Shu Y; Wang LS; Xu ZH; He N; Xiao WM; Wang W; Huang SL; Zhou HH
J Pharmacol Exp Ther; 2000 Nov; 295(2):844-51. PubMed ID: 11046127
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects.
Tybring G; Böttiger Y; Widén J; Bertilsson L
Clin Pharmacol Ther; 1997 Aug; 62(2):129-37. PubMed ID: 9284848
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactions.
Shirasaka Y; Sager JE; Lutz JD; Davis C; Isoherranen N
Drug Metab Dispos; 2013 Jul; 41(7):1414-24. PubMed ID: 23620487
[TBL] [Abstract][Full Text] [Related]
18. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
[TBL] [Abstract][Full Text] [Related]
19. A theoretical study of the dynamic behavior of alkane hydroxylation by a compound I model of cytochrome P450.
Yoshizawa K; Kamachi T; Shiota Y
J Am Chem Soc; 2001 Oct; 123(40):9806-16. PubMed ID: 11583542
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Functional Characterisation of Cytochrome P450 (CYP) 2C19 Allelic Variants CYP2C19*23 and CYP2C19*24.
Lau PS; Leong KV; Ong CE; Dong AN; Pan Y
Biochem Genet; 2017 Feb; 55(1):48-62. PubMed ID: 27578295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]